Turkish Journal of Medical Sciences
Volume 42

Number 2

Article 7

1-1-2012

Determination of changes in the basal metabolic rate and body
composition of patients with chronic active and inactive hepatitis
B infection using bioelectrical impedance analysis*
GÖKHAN UNUTMAZ
SÜDA TEKİN KORUK
CEMİL SERT

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
UNUTMAZ, GÖKHAN; KORUK, SÜDA TEKİN; and SERT, CEMİL (2012) "Determination of changes in the
basal metabolic rate and body composition of patients with chronic active and inactive hepatitis B
infection using bioelectrical impedance analysis*," Turkish Journal of Medical Sciences: Vol. 42: No. 2,
Article 7. https://doi.org/10.3906/sag-1101-1447
Available at: https://journals.tubitak.gov.tr/medical/vol42/iss2/7

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Original Article

G. UNUTMAZ, S. TEKİN KORUK, C. SERT
Turk J Med Sci
2012; 42 (2): 237-243
© TÜBİTAK
E-mail: medsci@tubitak.gov.tr
doi:10.3906/sag-1101-1447

Determination of changes in the basal metabolic rate and
body composition of patients with chronic active and inactive
hepatitis B infection using bioelectrical impedance analysis*
Gökhan UNUTMAZ1, Süda TEKİN KORUK2, Cemil SERT3

Aim: To examine changes in the basal metabolic rate and body composition of patients with chronic inactive and
active hepatitis B (HBV) infection as measured using single frequency bioelectrical impedance analysis (BIA) and to
investigate the convenience of this method for follow-up with these patients.
Materials and methods: Twenty patients with chronic inactive HBV infection, 22 with chronic active HBV infection,
and 43 healthy subjects were enrolled in the study. Using single frequency BIA and basal metabolic rate (BMR), the
resistance and body composition of all participants were measured.
Results: A total of 85 subjects (31 female and 54 male) with a mean age of 35.1 ± 11.4 years were enrolled. There was
no significant difference between the groups in terms of mean age, height, or body weight (P > 0.05). The mean body
mass index (BMI) of the participants was 26.55 kg/m². While the BMR was found to be lower, resistance was higher in
patients in the inactive group (P < 0.05 for both). The body fat index was higher in the inactive group than in the active
group, but the difference was not statistically significant (P > 0.05). A strong negative correlation was found between
BMR and resistance, and the body fat index (rho = –0.804, P < 0.01; rho = –0.337, P < 0.01, respectively). There was
a positive correlation between BMR and BMI (rho = 0.408, P < 0.05). There was no significant difference between the
groups BMI, phase angle, and other body components (P > 0.05).
Conclusion: This study suggests that single frequency BIA is less useful in the follow-up with the aforementioned group
of patients.
Key words: Chronic hepatitis B, bioelectric impedance, body composition

Kronik aktif ve inaktif hepatit B enfeksiyonlu hastalarda biyoelektrik empedans
analizi ile bazal metabolik hız ve vücut kompozisyonu değişimi
Amaç: Çalışmada, kronik inaktif ve aktif hepatit B enfeksiyonlu hastalarda tek frekans Biyoelektrik Empedans Analiz
(BIA) yöntemiyle bazal metabolik hızın ve vücut kompozisyonunun değişiminin saptanması ve bu yöntemin bu grup
hastaların takibinde uygulanabilirliğinin araştırılması amaçlandı.
Yöntem ve gereç: Çalışmaya, kronik inaktif HBV enfeksiyonlu 20 hasta ve kronik aktif HBV enfeksiyonlu 22 hasta ile
43 sağlıklı kontrol kişi dahil edildi. BIA yöntemi ile her gruptaki katılımcıların, bazal metabolik hız (BMR), rezistans ve
vücut kompozisyonları ölçüldü.
Bulgular: Çalışmaya yaş ortalaması 35,1 ± 11,4 yıl olan toplam 85 kişi (31’i kadın ve 54’ü erkek) katıldı. Çalışma grupları
yaş, boy ve vücut ağırlıkları açısından karşılaştırıldığında istatistiksel olarak farklılık yoktu (P > 0,05). Katılımcıların
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ortalama vücut kitle indeksi (VKİ) 26,55 kg/m² idi. Kronik inaktif hastalarda BMR düşük iken rezistans yüksek bulundu
(ikisi için P < 0,05). Kronik inaktif hastalarda vücut yağ oranı daha yüksek olmakla beraber aradaki fark istatistiksel
olarak anlamlı değildi (P > 0,05). BMR ile rezistans ve beden yağ indeksi arasında negatif yönde güçlü bir korelasyon
bulundu (sırasıyla, rho = –0,804, P < 0,01; rho = –0,337, P < 0,01). BMR ile VKİ arasında pozitif yönde bir korelasyon
vardı (rho = 0,408, P < 0.05). Gruplar VKİ, faz açısı ve diğer ölçülen vücut kompozisyonları açısından karşılaştırıldığında
anlamlı bir farklılık görülmedi (P > 0,05).
Sonuç: Sonuç olarak, çalışmamızın sonuçları bu grup hastalarda kullanılan tek frekans BİA yönteminin kronik hepatit
B enfeksiyonu olan hastaların izleminde daha az yararlı olduğu düşünülmektedir.
Anahtar sözcükler: Kronik hepatit B, biyoelektrik empedans, vücut kompozisyonu

Introduction

Materials and methods

Hepatitis B virus (HBV) is one of the most common
causes of acute/chronic hepatitis, cirrhosis, and
hepatocellular carcinoma. It is known that 400 million
people worldwide have chronic HBV infection, and
1-2 million people die annually because of HBV
infection and its complications (1).

Twenty-two patients with chronic inactive HBV
(CIHB) infection and 20 patients with chronic active
HBV (CAHB) infection presented to the Harran
University Medical Faculty in the Infectious Diseases
and Clinical Microbiology Department between
October 2008 and April 2009 and were enrolled in the
study. As a control group, 43 subjects with no known
cardiovascular, haematological, endocrinological,
or any other chronic diseases were also enrolled in
the study. Harran University Medical Faculty Ethical
Committee’s approval was obtained before starting
the study.

Currently, HBV infection rates are decreasing as a
result of effective vaccines, but the incidence of obesity
is steadily increasing worldwide (2). Symptoms
of metabolic syndrome, including fatty liver and
hepatic cell damage, are frequently observed in obese
people (3). Obesity, in conjunction with chronic viral
hepatitis, affects 100 million people. In the presence
of a disease that has a synergistic effect with obesity,
like HBV infection, the risk of fibrosis, cirrhosis, and
hepatocellular carcinoma increases (4,5). Therefore,
investigators have tried to find a quick, reliable, and
practical way of measuring the body composition of
individuals while investigating the correlation of these
2 public health issues using biochemical, viral, and
histopathological methods. One method that is being
evaluated is single frequency bioelectric impedance
analysis (BIA), which involves applying a stimulating
low level current to the body at a frequency of 50 kHz
and measuring the resistance (bioimpedance) against
this current. This is a non-invasive, easy, inexpensive,
portable, and effective method for establishing body
composition (6,7). The aim of the present study was
to determine changes in the basal metabolic rate and
body composition of patients with chronic active and
inactive hepatitis B infection using single frequency
BIA and, furthermore, to investigate the convenience
of this method for follow-up with patients.
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Patients who left the study; patients under the age
of 18 and over 60 years of age; patients using anti-lipid
medications or steroids; pregnant women; patients
with other concomitant liver disease (alcohol use,
hepatitis D infection, hepatitis C infection), hepatic
decomposition, or metal implants (prosthesis and
pacemakers); and immunosuppressed patients (HIV
infection, medicines, malignancies) were excluded
from the study.
The patients were diagnosed as having either
chronic inactive hepatitis B infection or chronic active
hepatitis B infection according to the guidelines (1).
Body weight was measured with a bascule, while the
patients wore the least clothes possible and no shoes.
Height was measured while the patients were barefoot, with their legs together in an upright position
using a height measuring scale. Body mass index
(BMI) was calculated using the following formula:
BMI = [weight (kg)/height (m2)]. BMI levels below
18.5 kg/m2 were defined as underweight, 18.5-24.9
kg/m2 as normal weight, 25-29.9 kg/m2 as overweight,
30-39.9 kg/m2 as obese, and 40 kg/m2 and above as
morbidly obese (8).
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The BIA method was used in this study to calculate
the components of the body. BIA relies on measuring
a vectorial magnitude called impedance (Z), following
the application of alternative current to the body
(9). Resistance is the defence the body exerts against
the conduction of electric current and is exerted by
extracellular cells (10). Reactance, on the other hand,
is the property of storing electric load for a certain
period of time. High reactance values depend on the
number of intact cell membranes and can be used
as an indirect measurement of body cell mass (6).
Bioelectric impedance analysis was performed on all
participants following 8 h of rest, and with an empty
stomach and bladder. The bio-dynamics BIA 450 (USA
Bioimpedance Analyser) was used. The participants
were told to drink 7-8 glasses of water the day before
the measurement and were advised to avoid tea, coffee,
and smoking. Before measurement, metal accessories
(belts, cell phones etc.) were removed. Each participant
was asked to lie on his or her back on the examination
table, without clothes. Standard tetrapolar electrodes
were used for measurement. A total of 4 electrodes
were utilised; 2 of the electrodes were placed 1 on the
right hand, 1 on the right hand wrist, and the 2 other
electrodes on the right foot and right ankle. The device
was turned on following the placement of electrodes;
patient data such as body weight and height were
recorded, and the measurement was performed. Body
composition parameters [body fat index (BFI), lean
body mass (LBM), total body water (TBW), and basal

metabolic rate (BMR)] as measured with BIA were
matched (age, weight, BMI) with the study group of
patients with chronic hepatitis B and were compared
to the control group.
When evaluating the data, the percentage, mean,
and standard deviation were calculated and used as
descriptive statistics. Since the groups in the study
did not comply with normal distribution and the
variances were not homogeneous, a non-parametric
test (Kruskal-Wallis) was used for comparison
between groups. The Bonferroni corrected KruskalWallis test was used to compare groups and the
Mann-Whitney U test was used to determine which
group was different. A P value < 0.05 was considered
significant. SPSS (Statistical Package for the Social
Sciences) software version 11.5 was used for the
statistical analysis.
Results
A total of 85 subjects (31 female and 54 male) with a
mean age of 35.1 ± 11.4 (min 18, max 60) years were
enrolled in the study including CIHB patients (n =
20, 12 male/8 female; mean age 35.2 ± 14.5 years),
CAHB patients (n = 22, 13 male/9 female; mean age
35.2 ± 11.2 years), and control patients (n = 43, 29
male/14 female; 35.0 ± 10.2 years). No significant
difference was observed when the study groups’ age,
gender, weight, or height was compared (P > 0.05)
(Table 1).

Table 1. Comparison of groups for age, height, and weight.
N

Mean value ± S.D.

Chi square*

df

P

0.084

2

0.959

0.98

2

0.952

1.974

2

0.353

Age (year)
Inactive

20

35.2 ± 14.5

Active

22

35.2 ± 11.2

Control

43

35.0 ± 10.2

Inactive

20

168.3 ± 7.3

Active

22

168.1 ± 6.0

Control

43

167.5 ± 9.5

Inactive

20

72.3 ± 11.3

Active

22

77.5 ± 12.9

Control

43

74.8 ± 14.8

Height (cm)

Weight (kg)

* Kruskal-Wallis test was used
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The mean body mass index of the participants
was 26.5 ± 4.3 kg/m2; 47.6% of them were overweight
and 21.4% were obese. The BMIs in CIHB, CAHB,
and control patients were 25.6 ± 4.3, 27.4 ± 4.4,
and 26.4 ± 4.1, respectively. The difference between
the groups’ BMIs was not statistically significant
(P > 0.05). A statistically significant difference and
positive correlation was observed between the BMI
and BMR, as well as between the BFI and age (rho =
0.408, P < 0.01; rho = 0.580, P < 0.01 and rho = 0.551,
P < 0.01, respectively).
No significant difference was observed regarding
the BMI and body fat indexes between CAHB
patients, CIHB patients, and controls.
The basal metabolic rate was lower in CIHB
patients. The difference was statistically significant
and this difference was due to the inactive hepatitis
B group (P < 0.05) (Table 2). A strong negative
correlation was found between BMR and resistance,
and the body fat index (rho = –0.804, P < 0.01; rho =
–0.337, P < 0.01, respectively). There was a positive
correlation between BMR and BMI (rho = 0.408, P <
0.05). Resistance was significantly higher in patients
with inactive HBV (P < 0.01) (Table 2). We found a
negative correlation between BMR and BMI (rho =
–0.804, P < 0.01; rho = –0.417, P < 0.01, respectively)
and a positive correlation with BFI (rho = 0.337, P <
0.01).

The phase angle was measured as 7.6° in the CIHB
patient group, 8.2° in the CAHB patient group, and
6.6° in the control group. There was no significant
difference between the groups (P > 0.05). However,
there was a negative correlation between the phase
angle and extracellular mass (ECM) (rho = –0.469, P <
0.01), and a strong positive correlation between body
cell mass (BCM) and intracellular water (ICW) (rho
= 0.636, P < 0.01; rho = 0.930, P < 0.01, respectively).
There was no significant difference between the phase
angle and age, BMR, BMI, resistance, or BFI (P >
0.05).
There was no significant difference in the BCM,
ECM, BFI, or ICW between the groups (P > 0.05)
(Table 3).
Discussion
Almost one third of the world’s population has been
infected with HBV (1). Turkey has an intermediate
prevalence of HBV infection (11). While the overall
incidence of HBV infection is decreasing because of
successful vaccination campaigns, the incidence of
obesity has been increasing worldwide. According to
data from the WHO, there are over 400 million obese
and approximately 1.6 billion overweight individuals
in the world (2).

Table 2. Comparison of groups for BMR and resistance.
N

Mean value ± S.D.

CIHB patients

20

1560.0 ± 269.5

CAHB patients

22

1776.8 ± 248.4

Controls

43

1724.9 ± 362.1

CIHB patients

20

638.0 ± 164.9

CAHB patients

22

512.0 ± 79.1

Controls

43

533.2 ± 98.8

Chi square*

df

P

6.38

2

0.041

10.03

2

0.007

BMR (calories)

Resistance (ohms)

* Kruskal-Wallis test was used
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Table 3. Comparison of groups with regard to BCM, ECM, BFI, and ICW.
N

Mean value ± S.D.

20

34.2 ± 9.7

CAHB patients

22

38.1 ± 5.4

Controls

43

35.7 ± 5.2

20

33.6 ± 8.1

CAHB patients

22

35.8 ± 7.6

Controls

43

38.1 ± 3.5

CIHB patients

20

32.0 ± 14.3

CAHB patients

22

26.0 ± 8.9

Controls

43

26.0 ± 6.9

20

57.4 ± 9.3

CAHB patients

22

59.8 ± 9.1

Controls

43

56.5 ± 4.9

BCM (kg) CIHB patients

ECM (kg) CIHB patients

BFI (%)

ICW (litre) CIHB patients

Chi square*

df

P

2.67

2

0.263

4.16

2

0.125

2.50

2

0.286

1.56

2

0.457

* Kruskal-Wallis test was used

In studies performed in Turkey regarding the
prevalence of obesity, the rates were found to be
18.6% in 1990, 22% in 2000, and 25.2% in 2002. These
figures suggest that the obesity rate is increasing in
Turkey (12,13). In the present study, the percentage of
obese participants was lower than the prevalence in
Turkey (25.2%) (12). The lower rate seen in this study
may be due to regional differences or to the small size
of the study group. Nevertheless, almost half of the
patients were within the limits of obesity. Chronic
hepatitis B cases are not exempt from the increasing
rate of obesity. These rates were calculated using
the BMI classification standardised by the WHO. It
is known that people with the same BMI can have
different muscle, bone, water, and fat ratios (14,15).
In defining obesity as a risk factor for metabolic
disorders, the excess fat ratio in the body is taken
into consideration (14). In our study, a positive and
statistically significant correlation was found between
BMI and the body fat index as calculated by the single
frequency BIA method.
In obese people, the metabolic syndrome
characteristics of fatty liver and liver cell damage
are frequently observed (3). While only fatty
liver was observed in some of the obese patients,
necroinflammation, fibrosis, and cirrhosis may

be seen in others. The reason for this is not fully
understood; however, alcohol consumption and
diseases that synergistically enhance the effects,
such as chronic hepatitis B or C infection, are likely
candidates (5,16). In Taiwan, patients with chronic
hepatitis B and chronic hepatitis C were followed
for 14 years, and it was established that diabetes
mellitus and obesity had a synergistic effect with viral
infection and that these patients had an increased risk
of developing hepatocellular cancer (HCC) that was
100 times greater than that of the normal population
(4). In a study by Chen et al., performed with antiHCV positive individuals, the obesity rate was higher
in the HCV RNA positive group than it was in the
HCV RNA negative group (32.1% versus 18.8%)
(4). In the present study, there was no significant
difference between the BMI and body fat index in
patients with chronically active HBV and high levels
of HBV DNA. In the literature, similar studies to
this have been performed for HCV infection. As our
study was performed with HBV infected patients,
the observed differences may be attributable to the
differences between viruses.
Altiparmak et al. performed a study wherein they
evaluated the role of fat deposition on liver damage
in patients with chronic hepatitis B infection and
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determined which viral and host factors cause fatty
liver. They found that metabolic factors in the host,
rather than the virus, affected fat deposition in these
patients (17). In our study, fat deposition was not
significantly different in CAHB patients whose viral
load was high. A negative correlation between the
phase angle measured by BIA and extracellular water
was observed; however, a strong positive correlation
was found between the body mass index and
intracellular water levels. There were no statistically
significant differences between phase angle and age,
basal metabolic rate, BMI, resistance, and the body fat
index in this study. On the other hand, Guida et al.
previously showed a correlation between high phase
angle and high BMI (18). While a decrease in phase
angle with an increase in age has been established,
Barbosa-Silva et al. have stated that the fat tissue
resistance may account for this correlation (19).
Selberg et al. found that a phase angle below 5.4° in
patients with liver cirrhosis is associated with a shorter
survival time (20). In contrast to previous studies, no
significant correlation was established between phase
angle and age or between BMI and body fat index in
our study.
When comparing bedside methods that are used
to measure the nutritional status of patients with
cirrhosis, the determination of body cell mass or phase
angle is considered to be superior to anthropometric
methods (21). On the other hand, in cirrhosis patients
with ascites, the single frequency BIA method is not
recommended for evaluation of the nutritional status,
for measurement of intra-abdominal ascites or for
follow-up (22).
Two recent publications disagreed about whether
BIA should be used to evaluate patients with hepatitis
C. Antaki et al. found that single frequency BIA did
not distinguish between minimal and advanced
degrees of hepatic fibrosis in patients with chronic
HCV infection (23). As in the present study, they
excluded patients with decompensated cirrhosis.
The study was designed as a pilot study with a small
group of patients. In contrast, Kahraman et al. found
that BIA offered a sophisticated analysis of body
composition including body fat, body cell mass, and
total body water for HCV patients following antiviral
therapy (24). In our study, the patients were examined
before and after antiviral treatment and compared
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to untreated HCV patients. Antiviral treatment for
HCV is often associated with fatigue, weight loss,
and anorexia (25). Therefore, single frequency BIA
detects some changes in body composition during
therapy.
In the present study, high phase angle values were
obtained in CIHB subjects, CAHB subjects, and the
control group. Our opinion, which is supported by
the literature, is that serious liver damage had not
yet developed in the patients included in the study
group because cirrhosis was an exclusion criterion;
therefore, we cannot draw conclusions regarding
serious liver damage.
Studies have shown that the results obtained by
single frequency BIA are similar to those obtained
by more complicated methods (densitometer,
calculation of total body water, etc.) (26, 27). However,
measurements performed at different times of day,
the electrodes and their position, skin heat, exercise,
eating/drinking, and postural changes can affect single
frequency BIA (28,29). In our study, to minimise the
margin of error the patients were prepared the day
before and the measurement was performed at the
same time of the day by the same person. However,
further studies are needed to determine the sources
of error before the method can be used as a reference
test.
In Turkey, millions of people have chronic
hepatitis B infection and/or obesity. Today, the longterm health risks of these diseases are well defined.
There is a need for methods that produce reliable
results and that can be used to establish and follow
changes in body composition. The development of
models that can perform automatic calculations and
the marketing of cheaper, smaller, and lighter devices
would increase their use in outpatient health care
and in field studies. This study and other literature
suggest that this method is less useful for follow-up
of the aforementioned group of patients.
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